Literature DB >> 6237011

Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena.

K C Herold, A Huen, L Gould, H Traisman, A H Rubenstein.   

Abstract

Previous studies have shown a variety of immunological abnormalities in Type 1 (insulin-dependent) diabetes, including disturbances in peripheral lymphocytes and anti-lymphocyte antibodies. We measured subsets of T and natural killer cells with monoclonal antibodies in patients with diabetes, and also assayed for anti-lymphocyte antibodies using dual colour immunofluorescence and flow cytometry. We found a significant decrease in numbers of Leu 3a (helper/inducer) cells in Type 1 diabetic patients of recent onset and intermediate levels in patients with longer duration of the disease. Leu 4 (pan T cell) levels were reduced in Type 1 diabetic patients of more than 4 months duration. Leu 7 (natural killer cells) were increased in Type 2 (non-insulin-dependent) diabetic patients. Individual Type 1 diabetic patients of recent onset showed low levels of Leu 7 and 11 a (natural killer cell) levels with normal 3a levels. Autoantibodies against Leu 3a + cells were present in higher titres in the Type 1 diabetic patients of recent onset than in control subjects. We conclude: (1) Leu 3a cells may be decreased in Type 1 diabetic patients of recent onset and return to normal with time; (2) low numbers of Leu 7 and 11a cells with normal numbers of Leu 3a may be seen in some Type 1 diabetic patients of recent onset, which may help explain previous reports of decreased suppressor cells; (3) Leu 7 levels may be increased in Type 2 diabetes; (4) autoantibodies against Leu 3a + peripheral lymphocytes may be seen in Type 1 diabetic patients of recent onset. These appear to be a marker of autoimmune phenomena rather than immunological mediators.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237011     DOI: 10.1007/bf00275660

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Glycosylated hemoglobins: increased glycosylation of hemoglobin A in diabetic patients.

Authors:  K H Gabbay; J M Sosenko; G A Banuchi; M J Mininsohn; R Flückiger
Journal:  Diabetes       Date:  1979-04       Impact factor: 9.461

2.  Anti-pancreatic cellular hypersensitivity in diabetes mellitus.

Authors:  J Nerup; O O Andersen; G Bendixen; J Egeberg; J E Poulsen
Journal:  Diabetes       Date:  1971-06       Impact factor: 9.461

3.  Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies.

Authors:  J R Wall; R Baur; H Schleusener; P Bandy-Dafoe
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

4.  Non-HLA lymphocyte cytotoxins in various diseases.

Authors:  G Ozturk; P I Terasaki
Journal:  Tissue Antigens       Date:  1979-07

5.  Insulin-dependent diabetes: a disease of autoaggression.

Authors:  S W Huang; N K Maclaren
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

6.  Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression.

Authors:  L L Lanier; M R Loken
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus.

Authors:  S Serjeantson; J Theophilus; P Zimmet; J Court; J R Crossley; R B Elliott
Journal:  Diabetes       Date:  1981-01       Impact factor: 9.461

8.  Characterization of seven C-peptide antisera.

Authors:  O K Faber; C Binder; J Markussen; L G Heding; V K Naithani; H Kuzuya; P Blix; D L Horwitz; A H Rubenstein
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

9.  Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat.

Authors:  T Dyrberg; A F Nakhooda; S Baekkeskov; A Lernmark; P Poussier; E B Marliss
Journal:  Diabetes       Date:  1982-03       Impact factor: 9.461

10.  Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.

Authors:  M Horita; H Suzuki; T Onodera; F Ginsberg-Fellner; A S Fauci; A L Notkins
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

View more
  18 in total

1.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 2.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

3.  Antibody Responses to Immunizations in Children with Type I Diabetes Mellitus: a Case-Control Study.

Authors:  Michael Eisenhut; Alexander Chesover; Ronald Misquith; Nisha Nathwani; Andrew Walters
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

4.  Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes.

Authors:  P Pozzilli; P Arduini; N Visalli; J Sutherland; M Pezzella; C Galli; S G Corradini; L Biasio; E A Gale; D Andreani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

5.  The effect of zinc status on the immune function of diabetic rats.

Authors:  A D Mooradian; D C Norman; J E Morley
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 6.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

7.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 8.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

9.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Cell-mediated autoimmunity at the onset of insulin-dependent diabetes mellitus (IDDM).

Authors:  A G Ziegler; E Standl; T Lander; C Nerl; E P Rieber; H Mehnert
Journal:  Klin Wochenschr       Date:  1987-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.